Deferoxamine
Iron Chelating Agents
- Drug class
- Iron Chelating Agents
- Availability
- See label
- Routes
- Intramuscular
- Markets covered
- 2
- Products on record
- 4
Overview
Deferoxamine is an active pharmaceutical ingredient in the Iron Chelating Agents group (V03AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 2 | March 13, 2026 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
2 products
Uses
g. g. g. severe anaemia, hypoproteinaemia, renal or cardiac failure) preclude phlebotomy. Treatment for acute iron poisoning. For the diagnosis of iron storage disease and certain anaemias. g. reverse osmosis) have failed and with proven aluminium-related bone disease and/or anaemia, dialysis encephalopathy; and for diagnosis of aluminium overload.
How to take
CACanada· Health Canada
2 products
Uses
AND CLINICAL USES ........................................................................... 3 CONTRAINDICATIONS .................................................................................................. 4 WARNINGS AND PRECAUTIONS .................................................................................
4 ADVERSE REACTIONS................................................................................................... 8 DRUG INTERACTIONS .................................................................................................
11 DOSAGE AND ADMINISTRATION ............................................................................. 12 OVERDOSAGE ...............................................................................................................
16 ACTION AND CLINICAL PHARMACOLOGY ........................................................... 17 STORAGE AND STABILITY ......................................................................................... 19 DOSAGE FORMS, COMPOSITION AND PACKAGING ............................................
Drug interactions
Known interactions involving Deferoxamine. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL245980020 · revised March 13, 2026
- [2]Health Canada (DPD) · 02241600 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.